These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 9046055

  • 1. The role of dystroglycan, a novel receptor of laminin and agrin, in cell differentiation.
    Matsumura K, Yamada H, Saito F, Sunada Y, Shimizu T.
    Histol Histopathol; 1997 Jan; 12(1):195-203. PubMed ID: 9046055
    [Abstract] [Full Text] [Related]

  • 2. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.
    Matsumura K, Campbell KP.
    Muscle Nerve; 1994 Jan; 17(1):2-15. PubMed ID: 8264699
    [Abstract] [Full Text] [Related]

  • 3. Dystroglycan and muscular dystrophies related to the dystrophin-glycoprotein complex.
    Sciandra F, Bozzi M, Bianchi M, Pavoni E, Giardina B, Brancaccio A.
    Ann Ist Super Sanita; 2003 Jan; 39(2):173-81. PubMed ID: 14587215
    [Abstract] [Full Text] [Related]

  • 4. Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses.
    Côté PD, Moukhles H, Lindenbaum M, Carbonetto S.
    Nat Genet; 1999 Nov; 23(3):338-42. PubMed ID: 10610181
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of dystroglycan binding to laminin disrupts the PI3K/AKT pathway and survival signaling in muscle cells.
    Langenbach KJ, Rando TA.
    Muscle Nerve; 2002 Nov; 26(5):644-53. PubMed ID: 12402286
    [Abstract] [Full Text] [Related]

  • 6. An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy.
    Moll J, Barzaghi P, Lin S, Bezakova G, Lochmüller H, Engvall E, Müller U, Ruegg MA.
    Nature; 2001 Sep 20; 413(6853):302-7. PubMed ID: 11565031
    [Abstract] [Full Text] [Related]

  • 7. Defective peripheral nerve myelination and neuromuscular junction formation in fukutin-deficient chimeric mice.
    Saito F, Masaki T, Saito Y, Nakamura A, Takeda S, Shimizu T, Toda T, Matsumura K.
    J Neurochem; 2007 Jun 20; 101(6):1712-22. PubMed ID: 17326765
    [Abstract] [Full Text] [Related]

  • 8. Dystroglycan expression in the wild type and mdx mouse neural retina: synaptic colocalization with dystrophin, dystrophin-related protein but not laminin.
    Montanaro F, Carbonetto S, Campbell KP, Lindenbaum M.
    J Neurosci Res; 1995 Nov 01; 42(4):528-38. PubMed ID: 8568939
    [Abstract] [Full Text] [Related]

  • 9. Sarcoglycan complex: a muscular supporter of dystroglycan-dystrophin interplay?
    Matsumura K, Saito F, Yamada H, Hase A, Sunada Y, Shimizu T.
    Cell Mol Biol (Noisy-le-grand); 1999 Sep 01; 45(6):751-62. PubMed ID: 10541473
    [Abstract] [Full Text] [Related]

  • 10. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma.
    Lapidos KA, Kakkar R, McNally EM.
    Circ Res; 2004 Apr 30; 94(8):1023-31. PubMed ID: 15117830
    [Abstract] [Full Text] [Related]

  • 11. [Severe childhood autosomal recessive muscular dystrophy].
    Matsumura K, Shimizu T.
    Rinsho Shinkeigaku; 1995 Dec 30; 35(12):1422-4. PubMed ID: 8752417
    [Abstract] [Full Text] [Related]

  • 12. Extracellular matrix and its receptors during development.
    Gullberg D, Ekblom P.
    Int J Dev Biol; 1995 Oct 30; 39(5):845-54. PubMed ID: 8645569
    [Abstract] [Full Text] [Related]

  • 13. Deficiency of the 50K dystrophin-associated glycoprotein in severe childhood autosomal recessive muscular dystrophy.
    Matsumura K, Tomé FM, Collin H, Azibi K, Chaouch M, Kaplan JC, Fardeau M, Campbell KP.
    Nature; 1992 Sep 24; 359(6393):320-2. PubMed ID: 1406935
    [Abstract] [Full Text] [Related]

  • 14. An adhesion molecule involved in muscular dystrophies: structural and functional analysis of dystroglycan domains.
    Brancaccio A.
    Ital J Biochem; 2003 Mar 24; 52(1):51-4. PubMed ID: 12833639
    [Abstract] [Full Text] [Related]

  • 15. Decreased expression of brain beta-dystroglycan in Duchenne muscular dystrophy but not in the mdx animal model.
    Finn DM, Culligan KG, Ohlendieck K.
    Biochem Biophys Res Commun; 1998 Aug 10; 249(1):231-5. PubMed ID: 9705863
    [Abstract] [Full Text] [Related]

  • 16. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy.
    Moore SA, Saito F, Chen J, Michele DE, Henry MD, Messing A, Cohn RD, Ross-Barta SE, Westra S, Williamson RA, Hoshi T, Campbell KP.
    Nature; 2002 Jul 25; 418(6896):422-5. PubMed ID: 12140559
    [Abstract] [Full Text] [Related]

  • 17. Sarcoglycans in muscular dystrophy.
    Hack AA, Groh ME, McNally EM.
    Microsc Res Tech; 2002 Jul 25; 48(3-4):167-80. PubMed ID: 10679964
    [Abstract] [Full Text] [Related]

  • 18. Transient expression of Dp140, a product of the Duchenne muscular dystrophy locus, during kidney tubulogenesis.
    Durbeej M, Jung D, Hjalt T, Campbell KP, Ekblom P.
    Dev Biol; 1997 Jan 15; 181(2):156-67. PubMed ID: 9013927
    [Abstract] [Full Text] [Related]

  • 19. Interactions between dystrophin and the sarcolemma membrane.
    Chamberlain JS, Corrado K, Rafael JA, Cox GA, Hauser M, Lumeng C.
    Soc Gen Physiol Ser; 1997 Jan 15; 52():19-29. PubMed ID: 9210217
    [Abstract] [Full Text] [Related]

  • 20. Dystroglycan glycosylation and its role in matrix binding in skeletal muscle.
    Martin PT.
    Glycobiology; 2003 Aug 15; 13(8):55R-66R. PubMed ID: 12736199
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.